Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B

Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B

Abstract This study evaluated the long-term efficacy and safety of the widely used drugs entecavir (ETV) and tenofovir alafenamide (TAF), as well as the incidence of HCC.A nonrandomized, prospective, observational analysis included 77 patients with chronic hepatitis B who were assigned to continue E...

Full description

Saved in:
Bibliographic Details
Main Authors: Takuya Matsubara, Satoru Hagiwara, Naoshi Nishida, Naoya Omaru, Akihiro Yoshida, Tomoki Yamamoto, Yoriaki Komeda, Mamoru Takenaka, Masatoshi Kudo
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Carcinogenesis
Efficacy
Entecavir
Hepatitis B virus
Safety
Tenofovir alafenamide
Online Access:https://doi.org/10.1038/s41598-025-85317-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-85317-3

Similar Items